SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882104-14-000071
Filing Date
2014-08-18
Accepted
2014-08-18 16:02:59
Documents
3
Period of Report
2014-08-18
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pdli-201408188xkdoc.htm 8-K 27270
2 PRESS RELEASE pdli-201408118xkex991.htm EX-99.1 140802
3 pdllogo75a01a01a01.jpg GRAPHIC 5218
  Complete submission text file 0000882104-14-000071.txt   176619
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 141049077
SIC: 2836 Biological Products, (No Diagnostic Substances)